The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1,1'-Biphenyl-4-yl)-3-(beta-D-glucopyranosyl)-1,2,4-triazole ID: ALA4176460
PubChem CID: 132281933
Max Phase: Preclinical
Molecular Formula: C20H21N3O5
Molecular Weight: 383.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: OC[C@H]1O[C@@H](c2nc(-c3ccc(-c4ccccc4)cc3)n[nH]2)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C20H21N3O5/c24-10-14-15(25)16(26)17(27)18(28-14)20-21-19(22-23-20)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,14-18,24-27H,10H2,(H,21,22,23)/t14-,15-,16+,17-,18-/m1/s1
Standard InChI Key: NIARDQNUDKGRGO-UYTYNIKBSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
19.5986 -3.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8895 -3.8136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8895 -4.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5986 -5.0393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1804 -5.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1804 -5.8565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4714 -4.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7664 -5.0393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4714 -3.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1804 -3.4091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7664 -3.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7664 -2.5919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3452 -3.7332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8934 -3.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4847 -2.4163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6841 -2.5859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7036 -3.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0346 -3.9603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8465 -4.0467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3282 -3.3855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9924 -2.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1815 -2.5531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1374 -3.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4694 -4.2160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2814 -4.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7623 -3.6395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4254 -2.8903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6144 -2.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
2 3 1 0
3 4 1 6
3 5 1 0
5 6 1 1
5 7 1 0
7 8 1 6
7 9 1 0
9 10 1 0
9 11 1 1
11 12 1 0
2 10 1 0
1 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 1 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 17 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
20 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.40Molecular Weight (Monoisotopic): 383.1481AlogP: 0.65#Rotatable Bonds: 4Polar Surface Area: 131.72Molecular Species: NEUTRALHBA: 7HBD: 5#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.49CX Basic pKa: 0.51CX LogP: 1.10CX LogD: 1.10Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.45Np Likeness Score: 0.17
References 1. Kun S, Begum J, Kyriakis E, Stamati ECV, Barkas TA, Szennyes E, Bokor É, Szabó KE, Stravodimos GA, Sipos Á, Docsa T, Gergely P, Moffatt C, Patraskaki MS, Kokolaki MC, Gkerdi A, Skamnaki VT, Leonidas DD, Somsák L, Hayes JM.. (2018) A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors., 147 [PMID:29453094 ] [10.1016/j.ejmech.2018.01.095 ]